Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 2

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 2Thoracic 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Colorectal Neoplasms 18Colonic Neoplasms 7Rectal Neoplasms 5Neoplasm Metastasis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Unresectable Metastatic Colorectal Cancer 2Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Prostatic Neoplasms 1Melanoma 1Lung Neoplasms 1Locally-advanced Rectal Cancer 1Gastroesophageal Adenocarcinoma 1Endometrial Neoplasms 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Folfox protocol × Clear all
NCT02009449 2024-11-15

IVY

Eli Lilly and Company

Phase 1 Completed
353 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04729205 2023-09-14

Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malignancies

Lipomedix Pharmaceuticals Inc.

Phase 1 Terminated
9 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00599924 2015-07-15

Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors

Pfizer

Phase 1 Completed
53 enrolled 31 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT00479583 2011-11-30

Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX

Bristol-Myers Squibb

Phase 1 Completed
25 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡